101 – 200 of 306
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF
(
- Contribution to journal › Article
-
Mark
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
(
- Contribution to journal › Article
-
Mark
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
40 Hz invisible spectral flicker and its potential use in Alzheimer's light therapy treatment
2020) Mechanisms of Photobiomodulation Therapy XV 2020 In Progress in Biomedical Optics and Imaging - Proceedings of SPIE 11221. p.1-12(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2019
-
Mark
Validation of a European Cross-Cultural Neuropsychological Test Battery (CNTB) for evaluation of dementia
(
- Contribution to journal › Article
-
Mark
APP depletion alters selective pre- and post-synaptic proteins
(
- Contribution to journal › Article
-
Mark
Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
A Potential Role for α -Amylase in Amyloid-β-Induced Astrocytic Glycogenolysis and Activation
(
- Contribution to journal › Article
-
Mark
Sex differences in predictors of mortality in patients with Alzheimer’s disease – A 20-year follow-up.
2019) 14th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2019)(
- Contribution to conference › Abstract
-
Mark
The cyanobacterial neurotoxin β-N-methylamino-L-alanine prevents addition of heparan sulfate to glypican-1 and increases processing of amyloid precursor protein in dividing neuronal cells
(
- Contribution to journal › Article
-
Mark
Validation of a brief Multicultural Cognitive Examination (MCE) for evaluation of dementia
(
- Contribution to journal › Article
-
Mark
Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease : Cross-validation study of practical algorithms
(
- Contribution to journal › Article
-
Mark
Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum
(
- Contribution to journal › Article
-
Mark
Preventing dementia by preventing stroke : The Berlin Manifesto
(
- Contribution to journal › Scientific review
-
Mark
On the Nature of β-Amyloid at Synapses
(
- Thesis › Doctoral thesis (compilation)
-
Mark
High occurrence of transportation and logistics occupations among vascular dementia patients : An observational study
(
- Contribution to journal › Article
-
Mark
A cortical microvascular structure in vascular dementia, Alzheimer's disease, frontotemporal lobar degeneration and nondemented controls : a sign of angiogenesis due to brain ischaemia?
(
- Contribution to journal › Article
-
Mark
Aging, metabolism, synaptic activity, and Aβ in Alzheimer's disease
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Cerebrospinal fluid concentrations of extracellular matrix proteins in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort : The ABIDE project
2019) In Alzheimer's and Dementia(
- Contribution to journal › Article
-
Mark
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals
(
- Contribution to journal › Article
-
Mark
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Discordant amyloid-β PET and CSF biomarkers and its clinical consequences
(
- Contribution to journal › Article
-
Mark
Early recognition and treatment of neuropsychiatric symptoms to improve quality of life in early Alzheimer's disease : Protocol of the BEAT-IT study
(
- Contribution to journal › Article
-
Mark
Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
(
- Contribution to journal › Article
-
Mark
Method comparison study of the Elecsys® β-Amyloid (1–42) CSF assay versus comparator assays and LC-MS/MS
(
- Contribution to journal › Article
-
Mark
Elecsys® Total-Tau and Phospho-Tau (181P) CSF assays : Analytical performance of the novel, fully automated immunoassays for quantification of tau proteins in human cerebrospinal fluid
(
- Contribution to journal › Article
-
Mark
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
(
- Contribution to journal › Article
- 2018
-
Mark
Levels of retinal IAPP are altered in Alzheimer's disease patients and correlate with vascular changes and hippocampal IAPP levels
(
- Contribution to journal › Article
-
Mark
SAR by kinetics for drug discovery in protein misfolding diseases
2018) In Proceedings of the National Academy of Sciences of the United States of America 115(41). p.10245-10250(
- Contribution to journal › Article
-
Mark
Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia : Prevalence and Presentation
(
- Contribution to journal › Article
-
Mark
Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease : A Case Report
(
- Contribution to journal › Article
-
Mark
Is intracranial volume a suitable proxy for brain reserve? Rik Ossenkoppele
(
- Contribution to journal › Scientific review
-
Mark
Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease : An experimental and theoretical study
(
- Contribution to journal › Article
-
Mark
No association of salivary total tau concentration with Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Biology/Disease-Driven Initiative on Protein-Aggregation Diseases of the Human Proteome Project : Goals and Progress to Date
(
- Contribution to journal › Article
-
Mark
The Impact of Amyloid Peptides on Pericytes in Alzheimer's Disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Apolipoprotein E genotypes and longevity across dementia disorders
(
- Contribution to journal › Article
-
Mark
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid biomarker levels: Total tau and phosphorylated tau as markers for rate of progression in Alzheimer’s disease.
2018) Advances in Alzheimer’s and Parkinson’s Therapies (AAT-AD/PD) Focus Meeting 2018(
- Contribution to conference › Abstract
-
Mark
The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease : Perspectives from the Research Roundtable
(
- Contribution to journal › Scientific review
-
Mark
Update on biomarkers for amyloid pathology in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Rapid amyloid-β oligomer and protofibril accumulation in traumatic brain injury
(
- Contribution to journal › Article
-
Mark
Altered structural network organization in cognitively normal individuals with amyloid pathology
(
- Contribution to journal › Article
-
Mark
Assessment of kallikrein 6 as a cross-sectional and longitudinal biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Prion-like seeding and nucleation of intracellular amyloid-β
(
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Brain alpha-amylase : a novel energy regulator important in Alzheimer disease?
(
- Contribution to journal › Article
- 2017
-
Mark
Plaque formation and the intraneuronal accumulation of β-amyloid in Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes
(
- Contribution to journal › Article
-
Mark
Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid
(
- Contribution to journal › Article
-
Mark
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders
(
- Contribution to journal › Article
-
Mark
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease
2017) In Proceedings of the National Academy of Sciences of the United States of America 114(2). p.200-208(
- Contribution to journal › Article
-
Mark
Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Association between Later Life Lifestyle Factors and Alzheimer's Disease Biomarkers in Non-Demented Individuals : A Longitudinal Descriptive Cohort Study
(
- Contribution to journal › Article
-
Mark
Preclinical effects of APOE ϵ4 on cerebrospinal fluid Aβ42 concentrations
(
- Contribution to journal › Article
-
Mark
Involvement of endosomal and synaptic Aβ in models of Alzheimer's disease.
2017)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Cerebrovascular and amyloid pathology in predementia stages : The relationship with neurodegeneration and cognitive decline
(
- Contribution to journal › Article
-
Mark
Predicting progression to dementia in persons with mild cognitive impairment using cerebrospinal fluid markers
(
- Contribution to journal › Article
-
Mark
Ponezumab in mild-to-moderate Alzheimer's disease : Randomized phase II PET-PIB study
2017) In Alzheimer's and Dementia: Translational Research and Clinical Interventions 3(3). p.393-401(
- Contribution to journal › Article
-
Mark
The frequency and influence of dementia risk factors in prodromal Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Time to amyloid positivity and preclinical changes in brain metabolism, atrophy, and cognition : Evidence for emerging amyloid pathology in alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
(
- Contribution to journal › Article
-
Mark
Exploring dementia management attitudes in primary care : a key informant survey to primary care physicians in 25 European countries
(
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
(
- Contribution to journal › Article
-
Mark
The interactive effect of demographic and clinical factors on hippocampal volume : A multicohort study on 1958 cognitively normal individuals
(
- Contribution to journal › Article
-
Mark
Amplifying mitochondrial function rescues adult neurogenesis in a mouse model of Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
The outcomes of different assessment scales can predict survival in patients with Alzheimer’s disease
2017) 13th International Conference on Alzheimer's and Parkinson's Diseases (AD/PD 2017) In Neurodegenerative Diseases 17(Suppl. 1). p.27-27(
- Contribution to journal › Published meeting abstract
-
Mark
Tau pathology distribution in Alzheimer's disease corresponds differentially to cognition-relevant functional brain networks
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid in Alzheimer's : A precious tool
(
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers
(
- Contribution to journal › Article
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
(
- Contribution to journal › Article
-
Mark
The endocytic pathway in microglia during health, aging and Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
Preclinical amyloid-β and axonal degeneration pathology in delirium
(
- Contribution to journal › Article
-
Mark
Amyloid beta aggregation kinetics : The role of intrinsic and extrinsic factors.
2016)(
- Thesis › Doctoral thesis (compilation)
-
Mark
Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Posterior accumulation of tau and concordant hypometabolism in an early-onset Alzheimer's disease patient with presenilin-1 mutation
(
- Contribution to journal › Article
-
Mark
Dysregulation of Elongation Factor 1A Expression is Correlated with Synaptic Plasticity Impairments in Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Cholinesterase inhibitors do not alter the length of stay in nursing homes among patients with Alzheimer's disease : A prospective, observational study of factors affecting survival time from admission to death.
(
- Contribution to journal › Article
-
Mark
Socioeconomic Predictors of the Employment of Migrant Care Workers by Italian Families Assisting Older Alzheimer's Disease Patients : Evidence from the Up-Tech Study
2016) In Journals of Gerontology - Series B Psychological Sciences and Social Sciences 71(3). p.514-525(
- Contribution to journal › Article
-
Mark
Short-term response to cholinesterase inhibitors in Alzheimer’s disease delays time to nursing home placement.
2016) 14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy In Neurobiology of Aging 39(Suppl. 1). p.2-2(
- Contribution to journal › Published meeting abstract
-
Mark
A methodological study of locus coeruleus degeneration in dementing disorders
(
- Contribution to journal › Article
- 2015
-
Mark
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease
(
- Contribution to journal › Scientific review
-
Mark
An Integrated Workflow for Multiplex CSF Proteomics and Peptidomics-Identification of Candidate Cerebrospinal Fluid Biomarkers of Alzheimer's Disease
(
- Contribution to journal › Article
-
Mark
Predicting Progression from Cognitive Impairment to Alzheimer's Disease with the Disease State Index
(
- Contribution to journal › Article
-
Mark
The economic impact of moderate stage Alzheimer's disease in Italy : Evidence from the UP-TECH randomized trial
(
- Contribution to journal › Article
-
Mark
Preanalytical confounding factors in the analysis of cerebrospinal fluid biomarkers for Alzheimer's disease : The issue of diurnal variation
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Charge Dependent Retardation of Amyloid beta Aggregation by Hydrophilic Proteins
(
- Contribution to journal › Article
-
Mark
SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer's disease
(
- Contribution to journal › Article
-
Mark
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
(
- Contribution to journal › Article
-
Mark
Markers of Prognosis in Neurodegenerative Dementia
(
- Thesis › Doctoral thesis (compilation)
-
Mark
A beta dimers differ from monomers in structural propensity, aggregation paths and population of synaptotoxic assemblies
(
- Contribution to journal › Article
-
Mark
The chaperone domain BRICHOS prevents CNS toxicity of amyloid-beta peptide in Drosophila melanogaster
(
- Contribution to journal › Article
-
Mark
Automatic temporal lobe atrophy assessment in prodromal AD: Data from the DESCRIPA study
(
- Contribution to journal › Article
- 2013
-
Mark
Fluid biomarkers in Alzheimer's disease - current concepts
(
- Contribution to journal › Scientific review